FYI
FDA
FDA Proposes Downgrading Bladder Cancer Detection Endoscopes from Class III to Class II
FDA seeks to reclassify diagnostic endoscopic light source systems for bladder cancer detection to Class II with special controls, eliminating premarket approval requirements. The FDA is proposing to reclassify diagnostic endoscopic light source systems (product code OAY) from Class III...
The deep analysis — cross-item commentary and how this topic has evolved — is part of SignalHealth Pro.
Start a 14-day Pro trial — $9/monthSources — verify every claim